Drug Patent Expirations for the Week of April 21, 2019

ADDERALL XR 25 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) Shire Patent: RE42096 Expiration: Apr 21, 2019 See More … For more information on how DrugPatentWatch can help with…
The post Drug Pate…


New patent expiration for Emd Serono drug CETROTIDE

Annual Drug Patent Expirations for CETROTIDE Cetrotide is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Emd Serono drug CETROTIDE appeared first on Drug…


Which pharmaceutical companies have the most spray dosed drugs?

This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most spray dosed drugs…
The post Which pharmaceutical companies have the most spray do…


New patent expiration for Astrazeneca Pharms drug OMNARIS

Annual Drug Patent Expirations for OMNARIS Omnaris is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Astrazeneca Pharms drug OMNARIS appea…


New patent expiration for SHIRE drug ADDERALL XR 5

Annual Drug Patent Expirations for ADDERALL+XR+5 Adderall Xr 5 is a drug marketed by Shire and is included in one NDA. It is available from six suppliers. There are four…
The post New patent expiration for SHIRE drug ADDERALL XR 5 appeared first on Dru…


Do NOT follow this link or you will be banned from the site!